Company intelligence
Aptar
About Aptar
Every day, Aptar creates “a-ha moments” for its customers and their consumers and patients by continually bringing innovations to market that convert non-dispensing packaging into breakthrough product-dispensing systems, including those that give people more effective ways to put on their favorite fragrance, kids the opportunity to pour ketchup without making a mess and patients connected technologies that help them more easily adhere to treatment. Aptar is a global leader in drug and consumer product dosing, dispensing and protection technologies. Aptar serves a number of attractive end markets including pharmaceutical, beauty, food, beverage, personal care and home care. Using market expertise, proprietary design, engineering and science to create innovative solutions for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has over 13,000 dedicated employees in 20 countries. For more information, visit www.aptar.com. All of Aptar's current job openings are found at jobs.aptar.com. Job applicants should be aware of recruiting scams on the Internet and social media platforms. The scammers frequently use a company’s logo and photos or the names of its executives to give the appearance of legitimacy. The fraud targets job seekers and uses false and fraudulent offers of employment with legitimate employers, like Aptar, to steal from the victims. No applicant for employment with Aptar is ever required to pay any money as part of the job application or hiring process. In addition, Aptar’s recruiting staff sends email communications to job applicants from email addresses with the “@aptar.com” domain name only. To read more about recruiting fraud or to report an incident please see Aptar's Recruiting Fraud Statement. https://aptar.com/careers/recruiting-fraud-statement/
Verified activity
Signals from Aptar
17 published signals
Presence & Recognition
Aptar received the German Packaging Award 2026 in the Sustainability category for its joint innovation with Werner & Mertz.
Reported by Aptar
Presence & Recognition
Aptar Pharma showcased capabilities across drug delivery at Nordic Life Science Days in Stockholm, featuring Injectables colleagues Aurélien Barré and Xavier Thiry.
Reported by Luke Williams
Partnerships
Aptar Pharma announced a collaboration with Aceso Therapeutics to advance the development of ACT-101, an antisense oligonucleotide candidate designed to target cystic fibrosis.
Reported by Aptar
Customers
Aptar Pharma's specialist inhalation development services business, Nanopharm Ltd, will lead formulation development and device assessment activities to support Aceso's clinical development roadmap for ACT-101.
Reported by Aptar
Presence & Recognition
Aptar Pharma Services is exhibiting at CPHI Milan 2026 from October 6-8 at Booth 11A43, Hall 11, featuring Nanopharm Ltd and Gateway Analytical.
Reported by Aptar
Presence & Recognition
Aptar announced the launch of its new product line
Reported by Dorota Lelonek
Presence & Recognition
Aptar participated in CPHI Milan 2026 from October 6-8 at Booth 11A43, Hall 11, featuring experts from Aptar Pharma Services, Nanopharm Ltd, and Gateway Analytical.
Reported by Holger Kehrer
Presence & Recognition
Aptar Pharma is a Gold Sponsor of the IPAC-RS Nasal Innovation Forum 2026 taking place September 16-17.
Reported by Aptar
Operations & Supply
Aptar operates in a day's work with a hot runner.
Reported by Joe Sweeney
People
Aptar welcomed new graduates to the Radolfzell GmbH.
Reported by Holger Kehrer
People
Aptar officially welcomed Gael Touya as President and CEO, and as a member of the Board of Directors.
Reported by Aptar
Presence & Recognition
Aptar Pharma and Nanopharm Ltd are attending the Exploring the Future of Inhalation Drug Delivery 2026 conference in Parma, Italy from September 8-10.
Reported by Aptar
People
Aptar welcomed Gael Touya to the company
Reported by Carolyn Penot
People
Aptar thanked Stephan Tanda for his leadership over the past nine years
Reported by Carolyn Penot
People
Aptar welcomed Gael Touya as its new President and CEO.
Reported by Stephan Tanda
Presence & Recognition
Aptar Pharma is attending CPHI Milan 2026 from October 6-8, 2026, at Booth 11A43, Hall 11.
Reported by Aptar
People
Aptar employee Stephan Tanda was nominated to the Board of Directors of the AkzoNobel Axalta MergeCo upon the closing of the merger.
Reported by Stephan Tanda